Delayed-type hypersensitivity to mofebutazone underlying a severe drug reaction.
Walchner
M
M
Dermatologische Klinik der Ludwig-Maximilians-Universität München, Germany.
Rueff
F
F
Przybilla
B
B
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004485:Eczema / Q000139:chemically induced; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects / Q000031:analogs & derivatives*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010653:Phenylbutazone; C002374:mofebutazone